Literature DB >> 9209020

The helicase domain of phage P4 alpha protein overlaps the specific DNA binding domain.

G Ziegelin1, R Calendar, R Lurz, E Lanka.   

Abstract

Replication initiation depends on origin recognition, helicase, and primase activities. In phage P4, a second DNA region, the cis replication region (crr), is also required for replication initiation. The multifunctional alpha protein of phage P4, which is essential for DNA replication, combines the three aforementioned activities on a single polypeptide chain. Protein domains responsible for the activities were identified by mutagenesis. We show that mutations of residues G506 and K507 are defective in vivo in phage propagation and in unwinding of a forked helicase substrate. This finding indicates that the proposed P loop is essential for helicase activity. Truncations of gene product alpha (gp alpha) demonstrated that 142 residues of the C terminus are sufficient for specifically binding ori and crr DNA. The minimal binding domain retains gp alpha's ability to induce loop formation between ori and crr. In vitro and in vivo analysis of short C-terminal truncations indicate that the C terminus is needed for helicase activity as well as for specific DNA binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209020      PMCID: PMC179226          DOI: 10.1128/jb.179.13.4087-4095.1997

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  31 in total

1.  Cnr protein, the negative regulator of bacteriophage P4 replication, stimulates specific DNA binding of its initiator protein alpha.

Authors:  G Ziegelin; R Calendar; D Ghisotti; S Terzano; E Lanka
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

2.  A DNA helicase induced by herpes simplex virus type 1.

Authors:  J J Crute; E S Mocarski; I R Lehman
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

3.  Replication of bacteriophage P4 DNA in a nonlysogenic host.

Authors:  B H Lindqvist; E W Six
Journal:  Virology       Date:  1971-01       Impact factor: 3.616

4.  5'-3' exonucleases in phosphorothioate-based oligonucleotide-directed mutagenesis.

Authors:  J R Sayers; W Schmidt; F Eckstein
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

5.  Lysogenization by satellite phage P4.

Authors:  R Calendar; E Ljungquist; G Deho; D C Usher; R Goldstein; P Youderian; G Sironi; E W Six
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

6.  The replication of bacteriophage P4 DNA in vitro. Partial purification of the P4 alpha gene product.

Authors:  M D Krevolin; R Calendar
Journal:  J Mol Biol       Date:  1985-04-20       Impact factor: 5.469

7.  A DNA primase specified by I-like plasmids.

Authors:  E Lanka; E Scherzinger; E Günther; H Schuster
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Plasmid RP4 specifies a deoxyribonucleic acid primase involved in its conjugal transfer and maintenance.

Authors:  E Lanka; P T Barth
Journal:  J Bacteriol       Date:  1981-12       Impact factor: 3.490

10.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

View more
  2 in total

1.  The repA gene of the linear Yersinia enterocolitica prophage PY54 functions as a circular minimal replicon in Escherichia coli.

Authors:  Günter Ziegelin; Nicole Tegtmeyer; Rudi Lurz; Stefan Hertwig; Jens Hammerl; Bernd Appel; Erich Lanka
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

2.  Cnr interferes with dimerization of the replication protein alpha in phage-plasmid P4.

Authors:  A Tocchetti; S Serina; I Oliva; G Dehò; D Ghisotti
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.